Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Researchers at the Stanford University School of Medicine have found a way to predict whether someone exposed to the flu virus is likely to become ill.
Purvesh Khatri, PhD, associate professor of medicine and of biomedical data science, and his team used a computational approach to pinpoint a blood-based genetic biomarker to determine an individual’s susceptibility to the disease.
“We’ve been after this for about four years,” Khatri said. “To our knowledge, it’s the first biomarker that shows susceptibility to influenza, across multiple strains.”
The biomarker is a gene called KLRD1, and it essentially acts as a proxy for the presence of a special type of immune cell that may be a key to stamping out nascent flu infection. Put simply: the more of this cell type found in a person’s blood, the lower their flu susceptibility. The research even hints at new avenues for pursuing a broadly applicable flu vaccine.
A paper describing the work will be published online June 14 in Genome Medicine. Khatri is the senior author. Graduate student Erika Bongen is the lead author.
The secret’s in the cell type
At the start of their study, Khatri and his group ran gene expression analyses that sifted through the collection of human genes, looking for a sign that one might be particularly important for fighting off the flu. But the sheer number of genes in a small number of samples overshadowed any potential signal, so Khatri turned to a different approach that repurposed immune cell data collected from more than 150 studies that monitored gene expression in the immune cells of more than 6,000 samples.
“The idea was, instead of looking at 20,000 variables [or genes], let’s bring it down to 20 ¾ let’s only look at 20 immune cell types and see if any of these shows a consistent pattern in regard to H1N1 or H3N2 flu infection, and then we’ll look at genes that are related to that cell type only,” Khatri said. “And that turned out to be the answer.”
Using a computational approach developed in his lab, Khatri and his team parsed the identity and proportion of cells present in participants of two studies — one conducted at Harvard University, the other at Duke University — comprising a total of 52 individuals who volunteered to sniff up live influenza in the name of science. The researchers were looking only at types of immune cells present in each individual just before they were infected with the flu.
“We found that a type of immune cell called a natural killer cell was consistently low at baseline in individuals who got infected,” Bongen said. Those who had a higher proportion of natural killer cells had better immune defenses and fought off illness.
“So we asked, ‘What are the genes that represent natural killer cells?’ And there turned out to be this one gene, KLRD1, that seemed to be a good target,” Bongen said.
Old data, new tricks
KLRD1, when expressed, manifests as a receptor on the surface of natural killer cells. KLRD1 is basically a counting chip. When the score was tallied, Khatri saw that, on the whole, those whose immune cells consisted of 10-13 percent natural killers did not succumb to the flu, whereas those whose natural killer cells fell short of 10 percent wound up ill. It’s a fine line, Khatri said, but the distinction between the groups is quite clear: Everyone who had 10 percent or more natural killer cells stood strong against the infection and showed no symptoms.
Khatri said his findings could help health professionals understand who’s at the highest risk for flu infection. “If, for example, there’s a flu epidemic going on, and Tamiflu supplies are limited, this data could help identify who should be prophylactically treated first,” Khatri said.
Khatri emphasizes that for now, the link between KLRD1 levels and influenza susceptibility is only an association. The next step, he said, is to find the mechanism.
“It will be crucial to understand the role of natural killer cells’ protection so that we can potentially leverage that in designing better flu vaccines,” he said. “Since we see that natural killer cells are protective across different strains, maybe that would be a path to a universal flu vaccine.”
More broadly, Khatri said that this research exemplifies the power of “data repurposing.”
“Our work shows how you can use data that exists from previous studies to answer questions that those studies alone would not have been able to answer,” Khatri said. “But by aggregating the data, we were able to find a signal across both studies and use that to discover something new.”
Receive an email update when we add a new INFLUENZA article.
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Influenza activity on the rise in Hamilton on December 17, 2018 at 8:04 am
The city's public health department is signalling the start of flu season in Hamilton. Hamilton Public Health says 56 cases of influenza had been confirmed across the city as of Dec. 8. READ MORE: Ham... […]
- Q&A: There are new vaccine options to help protect against influenza on December 17, 2018 at 6:47 am
Dear Mayo Clinic: I’ve read that there will be new options for getting the flu vaccine this year, including one for people who have egg allergies. How are these new vaccines different, and how ... […]
- UMass Amherst Biostatistician and National Team Assist CDC in Influenza Forecasting on December 17, 2018 at 4:50 am
AMHERST — When the Centers for Disease Control and Prevention (CDC) was looking for a preferred flu-prediction model for use in its flu-forecasting challenge this season, an influenza-tracking model d... […]
- Australia’s major cities are increasingly vulnerable to future influenza pandemics on December 17, 2018 at 3:04 am
Our cities are facing a growing vulnerability to pandemics, a University of Sydney research team has found. A large jump in arrivals by air and urbanisation are the two main factors that are making it ... […]
- Traveling Back: Spanish Influenza almost stopped Christmas from coming on December 14, 2018 at 11:52 am
1918 was a hard year, not only for Door County but for the entire world. The war in Europe had been raging for four years, taking the lives of young men as they fought and died on foreign battlefields ... […]
- CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks on December 12, 2018 at 11:09 pm
When the Centers for Disease Control and Prevention was looking for a preferred flu prediction model for use in its flu-forecasting challenge this season, an influenza-tracking model developed by a te... […]
- Pet Health: Canine Influenza on December 12, 2018 at 11:56 am
(KUSI) – Canine influenza is very similar to the human flu and Dr. Angela Gaeto from Helen Woodward Animal Center visited Good Morning San Diego to discuss what owners can do to keep your pets from ge... […]
- Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: Results of a census-calibrated model on December 12, 2018 at 11:19 am
1 Complex Systems Research Group, School of Civil Engineering, Faculty of Engineering and IT, The University of Sydney, Sydney, NSW 2006, Australia. 2 Marie Bashir Institute for Infectious Diseases an... […]
- 'Influenza' and 'Pandemic 1918' review: Books by Dr. Jeremy Brown and Catharine Arnold document how the flu killed 50-100 million on December 12, 2018 at 4:28 am
INFLUENZA: The Hundred-Year Hunt to Cure the Deadliest Disease in History, by Dr. Jeremy Brown. Touchstone, 258 pp., $26.99. PANDEMIC 1918: Eyewitness Accounts from the Greatest Medical Holocaust in M... […]
via Bing News